🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →
S&P 500: 754.37 -0.4% NASDAQ 100: 679.89 -1.2% Dow Jones: 534.08 -0.5%

Lionhunter Capital Management - Q3 2026 13F Filings

LI

Lionhunter Capital Management, LLC

CIK: 0002137268
Address: New York New York 90 Broad Street Suite 215
$224.27 M
Portfolio Value
108
Assets Held
Reporting Period: Q3 2026
Filing Status:
Active
Last Updated: 11/13/2026

Portfolio Summary (Q3 2026)

View Full Portfolio Analysis

Top Buys

Q3 2026
1. BSX Boston Scientific Corporation
+$4.02 M
2. GMAB Genmab A/S
+$2.96 M
3. META Meta Platforms
+$2.54 M
4. VRDN Viridian Therapeutics
+$2.26 M
5. GIS General Mills
+$2.12 M

Top Sells

Q3 2026
1. HON Honeywell International
−$3.41 M
2. HONA Honeywell Aerospace
−$3.36 M
3. KRMD Koru Medical Systems
−$2.91 M
4. VNDA Vanda Pharmaceuticals
−$2.45 M
5. GOOGL Alphabet
−$2.11 M

Asset Allocation

Stocks/ETFs
+1.12%
$224.27 M 100.00%
Options
$0 0.00%
Debt
$0 0.00%
Other
$0 0.00%

Sector Allocation (Stocks)

Lionhunter Capital Management Q3 2026 Filing Summary

Lionhunter Capital Management, LLC filed its 13F report for Q3 2026 on November 13, 2026. The portfolio totaled 224.27 M reflecting a +1.12% change from the prior quarter, spanning 108 assets. The top 10 holdings comprised 40.0% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 12 new positions and 13 complete exits.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Lionhunter Capital Management’s Q3 2026 Filing

Lionhunter Capital Management submitted their Form 13F-HR for the Q3 2026 period on 11/13/2026. This was the only submission for the quarter.

In the Q3 2026 filing, Lionhunter Capital Management reported a managed portfolio value of 224.27 M, consisting of 108 individual positions.

This page displays the raw filing documents. To see which stocks Lionhunter Capital Management bought or sold during Q3 2026, please visit Lionhunter Capital Management's Portfolio Analysis page.